Cargando…
Membrane mesothelin expression positivity is associated with poor clinical outcome of luminal-type breast cancer
Mesothelin is expressed in various types of malignant tumors. The present study immunohistochemically investigated mesothelin expression and its clinicopathological significance in each subtype of breast cancer, with special reference to its cellular localization, in particular, membrane mesothelin...
Autores principales: | Suzuki, Takafumi, Yamagishi, Yoji, Einama, Takahiro, Koiwai, Tomomi, Yamasaki, Tamio, Fukumura-Koga, Makiko, Ishibashi, Yusuke, Takihata, Yasuhiro, Shiraishi, Takehiro, Miyata, Yoichi, Iwasaki, Toshimitsu, Shinto, Eiji, Sato, Kimiya, Ueno, Hideki, Yamamoto, Junji, Kishi, Yoji, Tsuda, Hitoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7479516/ https://www.ncbi.nlm.nih.gov/pubmed/32952662 http://dx.doi.org/10.3892/ol.2020.12055 |
Ejemplares similares
-
Co-expression of mesothelin and CA125/MUC16 is a prognostic factor for breast cancer, especially in luminal-type breast cancer patients
por: Einama, Takahiro, et al.
Publicado: (2021) -
Comparison between AJCC 8th prognostic stage and UICC anatomical stage in patients with primary breast cancer: a single institutional retrospective study
por: Tanaka, Ryo, et al.
Publicado: (2020) -
Metachronous bilateral triple-negative breast cancer associated with neurofibromatosis type 1: A case report
por: Yamagishi, Yoji, et al.
Publicado: (2019) -
Utility of (18)F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Fusion Imaging for Prediction of Metastasis to Sentinel and Nonsentinel Nodes in Patients with Clinically Node-Negative Breast Cancer
por: Yamagishi, Yoji, et al.
Publicado: (2020) -
Dual time point (18)F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging ((18)F-FDG PET/CT) in primary breast cancer
por: YAMAGISHI, Yoji, et al.
Publicado: (2019)